Wen‐Kuan Huang

1.4k total citations
82 papers, 905 citations indexed

About

Wen‐Kuan Huang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Wen‐Kuan Huang has authored 82 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 20 papers in Surgery. Recurrent topics in Wen‐Kuan Huang's work include Gastrointestinal Tumor Research and Treatment (8 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Wen‐Kuan Huang is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (8 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Wen‐Kuan Huang collaborates with scholars based in Taiwan, Sweden and China. Wen‐Kuan Huang's co-authors include Lai‐Chu See, Kuang‐Hui Yu, Jen‐Shi Chen, Chun‐Nan Yeh, Chang‐Fu Kuo, Chiao‐En Wu, Dong‐Yi Chen, Lu Huang, Yung‐Chang Lin and John Wen‐Cheng Chang and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Journal of Materials Chemistry A.

In The Last Decade

Wen‐Kuan Huang

73 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Kuan Huang Taiwan 18 281 226 169 146 144 82 905
Sung‐Hyun Kim South Korea 17 371 1.3× 223 1.0× 213 1.3× 95 0.7× 136 0.9× 105 1.0k
Xiaoyang Li China 20 291 1.0× 281 1.2× 279 1.7× 77 0.5× 157 1.1× 89 1.2k
Yuki Kojima Japan 17 379 1.3× 149 0.7× 207 1.2× 115 0.8× 177 1.2× 104 983
Aikaterini Mastoraki Greece 18 311 1.1× 302 1.3× 276 1.6× 119 0.8× 444 3.1× 81 1.1k
Conor O’Keane Ireland 17 147 0.5× 168 0.7× 254 1.5× 86 0.6× 189 1.3× 44 1.1k
Sadir Alrawi United States 17 302 1.1× 206 0.9× 222 1.3× 98 0.7× 302 2.1× 48 911
Sangjoon Choi South Korea 15 176 0.6× 157 0.7× 124 0.7× 87 0.6× 159 1.1× 63 681
Frank S. Fan Taiwan 20 358 1.3× 224 1.0× 256 1.5× 117 0.8× 366 2.5× 84 1.4k
Tsu‐Yi Chao Taiwan 18 337 1.2× 170 0.8× 212 1.3× 139 1.0× 217 1.5× 61 1.1k

Countries citing papers authored by Wen‐Kuan Huang

Since Specialization
Citations

This map shows the geographic impact of Wen‐Kuan Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Kuan Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Kuan Huang more than expected).

Fields of papers citing papers by Wen‐Kuan Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Kuan Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Kuan Huang. The network helps show where Wen‐Kuan Huang may publish in the future.

Co-authorship network of co-authors of Wen‐Kuan Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Kuan Huang. A scholar is included among the top collaborators of Wen‐Kuan Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Kuan Huang. Wen‐Kuan Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Wen‐Kuan, Po‐Jung Su, Ming‐Jer Hsieh, et al.. (2025). Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan. Journal of Cancer Research and Clinical Oncology. 151(11). 284–284.
2.
Chen, Dong‐Yi, Ming‐Jer Hsieh, Tien‐Hsing Chen, et al.. (2025). Predicting Cardiovascular Risk in Patients with Prostate Cancer Receiving Abiraterone or Enzalutamide by Using Machine Learning. Cancers. 17(15). 2414–2414. 1 indexed citations
3.
4.
Huang, Wen‐Kuan. (2024). Efficacy of first-line combination therapies versus gemcitabine monotherapy for advanced pancreatic cancer: a systematic review and network meta-analysis. American Journal of Cancer Research. 14(7). 3523–3532. 1 indexed citations
5.
Chen, Dong‐Yi, et al.. (2024). The cold temperature associated with new-onset heart failure after incorporating dynamic status of multimorbidity: nationwide cohort, Taiwan 2012–2019. European Journal of Preventive Cardiology. 31(17). 2026–2035. 1 indexed citations
6.
Huang, Wen‐Kuan, Pei‐Hua Peng, Shih‐Ming Jung, et al.. (2023). PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions. Cancer Gene Therapy. 31(2). 322–333. 2 indexed citations
7.
Chang, John Wen‐Cheng, Wen‐Kuan Huang, Yu‐Chao Wang, et al.. (2023). Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma. Clinical & Translational Immunology. 12(8). e1465–e1465. 2 indexed citations
8.
Wu, Chiao‐En, Shih‐Chiang Huang, Sheng‐Hsuan Lin, et al.. (2023). Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation. International Journal of Biological Sciences. 19(9). 2772–2786. 7 indexed citations
9.
Tseng, Chi‐Nan, et al.. (2023). Ambient Temperature Effect on Acute Myocardial Infarction by Risk Factors. JACC Asia. 3(2). 228–238. 4 indexed citations
10.
Yeh, Chun‐Nan, et al.. (2023). Wee1 inhibition by MK1775 potentiates gemcitabine through accumulated replication stress leading to apoptosis in biliary tract cancer. Biomedicine & Pharmacotherapy. 166. 115389–115389. 5 indexed citations
11.
Yeh, Chun‐Nan, et al.. (2023). A Potential Association of Zinc Deficiency and Tyrosine Kinase Inhibitor-Induced Hand-Foot Skin Reaction. Biological Trace Element Research. 201(12). 5540–5545. 4 indexed citations
12.
Chang, Pei‐Hung, Kun‐Yun Yeh, Hung‐Ming Wang, et al.. (2022). Association of early changes of circulating cancer stem-like cells with survival among patients with metastatic breast cancer. Therapeutic Advances in Medical Oncology. 14. 4287522214–4287522214. 1 indexed citations
13.
Huang, Wen‐Kuan, Pınar Akçakaya, Katarina Zeljić, et al.. (2021). Imatinib Regulates miR-483-3p and Mitochondrial Respiratory Complexes in Gastrointestinal Stromal Tumors. International Journal of Molecular Sciences. 22(19). 10600–10600. 7 indexed citations
14.
Wu, Chiao‐En, Wen‐Kuan Huang, Wen‐Chi Chou, et al.. (2021). Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy. Cancers. 13(13). 3139–3139. 4 indexed citations
15.
16.
Huang, Wen‐Kuan & Chun‐Nan Yeh. (2020). The Emerging Role of MicroRNAs in Regulating the Drug Response of Cholangiocarcinoma. Biomolecules. 10(10). 1396–1396. 8 indexed citations
17.
Wu, Chiao‐En, Da‐Wei Yeh, Wen‐Kuan Huang, et al.. (2020). Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis. Life. 10(11). 276–276. 12 indexed citations
18.
Huang, Wen‐Kuan, Jiwei Gao, Ziqing Chen, et al.. (2020). Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor. Cells. 9(6). 1333–1333. 17 indexed citations
19.
Huang, Wen‐Kuan, Hung‐Chih Hsu, Wen‐Chi Chou, et al.. (2020). Postdiagnostic metformin use and survival of patients with colorectal cancer: A Nationwide cohort study. International Journal of Cancer. 147(7). 1904–1916. 10 indexed citations
20.
Xu, Jianzhong, et al.. (2017). [The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].. PubMed. 56(12). 924–929. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung‐Hyun Kim Breakdown of academic impact, for papers by Xiaoyang Li Breakdown of academic impact, for papers by Yuki Kojima Breakdown of academic impact, for papers by Aikaterini Mastoraki Breakdown of academic impact, for papers by Conor O’Keane Breakdown of academic impact, for papers by Sadir Alrawi Breakdown of academic impact, for papers by Sangjoon Choi Breakdown of academic impact, for papers by Frank S. Fan Breakdown of academic impact, for papers by Tsu‐Yi Chao
Rankless by CCL
2026